» Articles » PMID: 39735412

Association Between Infection and Serum Neurotransmitter Levels in Major Depressive Disorder Patients: A Case-Control Study in Bangladesh

Overview
Journal J Parasitol Res
Publisher Wiley
Specialty Parasitology
Date 2024 Dec 30
PMID 39735412
Authors
Affiliations
Soon will be listed here.
Abstract

() is an obligate, intracellular, neurotropic protozoan parasite. After primary infection, parasite undergoes stage conversion from fast-replicating tachyzoites to slow-replicating dormant bradyzoites, particularly in the brain, and persists for a lifetime of an individual. In this study, the impact of infection in individuals with psychological disorder, that is, major depressive disorder (MDD) has been studied. Ninety-five MDD ( = 95) patients were enrolled with age and sex-matched healthy controls (HCs, = 90). The seroprevalence of infection among these individuals was determined using the TOXO IgM/IgG Rapid Test Cassette that determines the anti- IgM and IgG antibodies in the serum samples. Furthermore, to understand the impact of in developing major depression, the serum level of neurotransmitters (i.e., dopamine, adrenaline, and noradrenaline) was determined using an enzyme-linked immunosorbent assay (ELISA). Our data suggest that anti- IgG was slightly higher in MDD patients than in HCs. The level of dopamine was significantly lower in -infected MDD patients than in HCs. However, adrenaline and noradrenaline levels showed increasing levels in -infected MDD patients. The level of neurotransmitters was correlated with the DSM-D scores of MDD patients. These data, nevertheless, confirm that might affect the level of neurotransmitters in MDD patients. However, whether the reduced level of dopamine and increased level of adrenaline and noradrenaline act as contributing factors for the development of MDD is yet to be known.

References
1.
Flegr J, Prandota J, Sovickova M, Israili Z . Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One. 2014; 9(3):e90203. PMC: 3963851. DOI: 10.1371/journal.pone.0090203. View

2.
Otte C, Gold S, Penninx B, Pariante C, Etkin A, Fava M . Major depressive disorder. Nat Rev Dis Primers. 2016; 2:16065. DOI: 10.1038/nrdp.2016.65. View

3.
Edvinsson B, Lundquist J, Ljungman P, Ringden O, Evengard B . A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation. APMIS. 2008; 116(5):345-51. DOI: 10.1111/j.1600-0463.2008.00871.x. View

4.
Mogi T, Toda H, Yoshino A . Clinical characteristics of patients with diagnostic uncertainty of major depressive disorder. Asian J Psychiatr. 2017; 30:159-162. DOI: 10.1016/j.ajp.2017.10.001. View

5.
. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1789-1858. PMC: 6227754. DOI: 10.1016/S0140-6736(18)32279-7. View